Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection
- 1 April 2000
- journal article
- review article
- Published by Elsevier
- Vol. 21 (4) , 149-154
- https://doi.org/10.1016/s0165-6147(00)01451-6
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Oxidative stress as a mechanism for quinolinic acid‐induced hippocampal damage: protection by melatonin and deprenylBritish Journal of Pharmacology, 1999
- Glutamate‐induced mitochondrial depolarisation and perturbation of calcium homeostasis in cultured rat hippocampal neuronesThe Journal of Physiology, 1999
- 3‐Hydroxykynurenine, an Endogenous Oxidative Stress Generator, Causes Neuronal Cell Death with Apoptotic Features and Region SelectivityJournal of Neurochemistry, 1998
- 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptorJournal of Medicinal Chemistry, 1992
- Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenateBritish Journal of Pharmacology, 1990
- Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptorEuropean Journal of Pharmacology, 1988
- Actions of excitatory amino acids and kynurenic acid in the primate hippocampus: A preliminary studyNeuroscience Letters, 1984
- Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat BrainScience, 1983
- An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acidBrain Research, 1982
- Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNSEuropean Journal of Pharmacology, 1981